Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Applying lessons learned from sars to develop live vaccines against MERS

AuthorsEnjuanes Sánchez, Luis CSIC ORCID ; Nieto-Torres, José L. ; DeDiego, Marta L. CSIC ORCID ; Jiménez-Guardeño, José Manuel CSIC ORCID ; Regla-Nava, José Ángel ; Castaño-Rodríguez, Carlos ; Fernandez-Delgado, Raúl ; Gutierrez-Alvarez, Francisco J. ; Cantón, Javier ; Zúñiga Lucas, Sonia CSIC ORCID ; Solá Gurpegui, Isabel CSIC ORCID
Issue Date10-Oct-2016
CitationWorld Vaccines Congress Europe (2016)
AbstractThe emergence of viruses causing diseases in humans is constant in History. Most emergent viruses have been transmitted from animal hosts to humans (zoonosis). Coronaviruses (CoVs) have frequently crossed the species barriers and two novel coronaviruses have caused important zoonosis in the twenty-first century. Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 in South East China and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 in Saudi Arabia. Both viruses cause acute respiratory distress syndrome and are associated with high mortality rates, around 10% and 35% respectively. However, mortality rat s higher than 50% are observed in the aged and immunosuppressed populations
DescriptionTrabajo presentado en el World Vaccines Congress Europe 2016, celebrado en Barcelona (España), del 10 al 12 de octubre de 2016
Appears in Collections:(CNB) Comunicaciones congresos
(PTI Salud Global) Colección Especial COVID-19

Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Page view(s)

checked on Mar 2, 2024


checked on Mar 2, 2024

Google ScholarTM


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.